Abstract
We report a parkinsonian patient who presented an adynamic bowel syndrome after l-dopa withdrawal during the course of a febrile illness. Due to lack of response to l-dopa attributable to gastrointestinal (GI) motility impairment, apomorphine treatment was started, and the adynamic bowel syndrome dramatically improved. The use of apomorphine in Parkinson's disease patients with acute GI motility disorders is recommended.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
